Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) EVP Bryant Yates sold 11,968 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $19.90, for a total transaction of $238,163.20. Following the completion of the sale, the executive vice president directly owned 77,446 shares of the company’s stock, valued at $1,541,175.40. The trade was a 13.38% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Nature’s Sunshine Products Stock Performance
Shares of NATR opened at $20.40 on Friday. The company has a 50 day moving average price of $23.84 and a 200-day moving average price of $23.81. Nature’s Sunshine Products, Inc. has a fifty-two week low of $12.97 and a fifty-two week high of $28.14. The stock has a market capitalization of $358.63 million, a PE ratio of 18.55 and a beta of 0.86.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.20 by $0.10. The firm had revenue of $122.89 million during the quarter, compared to analyst estimates of $122.15 million. Nature’s Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%.
Institutional Trading of Nature’s Sunshine Products
Wall Street Analyst Weigh In
NATR has been the topic of several recent research reports. Canaccord Genuity Group set a $37.00 price objective on shares of Nature’s Sunshine Products in a report on Friday, May 8th. Weiss Ratings downgraded shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday. Finally, DA Davidson reaffirmed a “buy” rating and issued a $33.00 price objective on shares of Nature’s Sunshine Products in a report on Monday, May 11th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Nature’s Sunshine Products has an average rating of “Moderate Buy” and an average target price of $35.00.
Read Our Latest Stock Analysis on Nature’s Sunshine Products
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Recommended Stories
- Five stocks we like better than Nature’s Sunshine Products
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
